Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Wunderink, Richard G, Matsunaga, Yuko, Ariyasu, Mari, Clevenbergh, Philippe, Echols, Roger, Kaye, Keith S, Kollef, Marin, Menon, Anju, Pogue, Jason M, Shorr, Andrew F, Timsit, Jean-Francois, ZeitlingeJournal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(20)30731-3
Date:
October, 2020
File:
PDF, 1.09 MB
2020
File converter
More search results
More benefits 
